Mecure Industries PLC (NGX:MECURE)

Market Cap	273.20B +444.2%
Revenue (ttm)	77.69B +68.8%
Net Income	6.46B +177.5%
EPS	1.62 +179.3%
Shares Out	4.00B
PE Ratio	42.16
Forward PE	n/a
Dividend	0.15 (0.20%)
Ex-Dividend Date	Apr 22, 2025

Volume	310,797
Average Volume	181,876
Open	68.30
Previous Close	75.85
Day's Range	68.30 - 68.30
52-Week Range	11.10 - 104.00
Beta	1.57
RSI	13.54
Earnings Date	Feb 26, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company also engages in distributing multivitamins products. In addition, it offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. Further, it provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Additionally, it involved in the contract manufacturing services. It sells its products thr...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 192
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: MECURE

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.